SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; SPIRONOLACTONE) — FDA Approval ANDA085974 (WATSON LABS)
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; SPIRONOLACTONE) — FDA Approval ANDA085974 (WATSON LABS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE; Application number: A
| Brand name | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
| Application number | ANDA085974 |
| Sponsor | WATSON LABS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →